These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. Teleflex is the home of Arrow ®, Deknatel ®, Hudson RCI ®, LMA ®, Pilling ®, Rusch ®, UroLift ®, and Weck ® – trusted brands united by a common sense of purpose.Īny statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. For more information about the GuideLiner ®V3 Catheter, visit Teleflex.link/guideliner. The GuideLiner ®V3 Catheter will be featured in Teleflex booth 1251 at TCT 2019, September 25-29 at the Moscone Center in San Francisco. No collar separations have been reported in PCI for the GuideLiner ®V3 Catheter. In addition, the GuideLiner ®V3 Catheter's unique half-pipe channel is designed to minimize device/collar interactions by directing and aligning the devices through the collar transition, facilitating smooth device entry and seamless delivery. 3 With this in mind, we selected a silicone coating that testing has shown provides superior back-up support, while still providing the deliverability to get the GuideLiner V3 Catheter to where it needs to go." "A fully hydrophilic-coated extension can improve deliverability, but can result in the loss of valuable backup support within the guide. 2 "In developing the GuideLiner V3 Catheter, we understood that physicians wanted flexibility for easy, atraumatic delivery, without sacrificing the very backup support they sought in a device," said Josh Brenizer, Principal R&D Engineer for the GuideLiner ®V3 Catheter. The GuideLiner ®V3 Catheter's coil-reinforced guide extension offers greater longitudinal flexibility and shape retention that is less kinkable than braid-reinforced designs. "The GuideLiner V3 Catheter offers improved guide catheter support, allowing us to deliver devices with ease to treat these complex vessels." 1 Amir Ravandi, interventional cardiologist and associate professor of medicine at St. "In the current practice of interventional cardiology, we increasingly deal with tortuous and calcified vessels," said Dr.
Guide extension catheters are designed to give interventionalists the support they to need to navigate to diseased, calcified lesions and deliver other devices to treat a diseased vessel.
0 kommentar(er)
